title: Risk of nonmelanoma skin cancer in patients with inflammatory bowel disease who use thiopurines is not increased.
authors.forename: Fiona D M
authors.initials: FD
authors.lastname: van Schaik
authors.forename: Martijn G H
authors.initials: MG
authors.lastname: van Oijen
authors.forename: Hugo M
authors.initials: HM
authors.lastname: Smeets
authors.forename: Geert J M G
authors.initials: GJ
authors.lastname: van der Heijden
authors.forename: Peter D
authors.initials: PD
authors.lastname: Siersema
authors.forename: Bas
authors.initials: B
authors.lastname: Oldenburg
mesh_terms: D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage* / Q000009:adverse effects*; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000139:chemically induced / Q000453:epidemiology*
chemical_list: D007166:Immunosuppressive Agents; D015122:Mercaptopurine